Compare $AZTA vs $CTKB | Chartloom

Compare

$AZTA vs $CTKB

Azenta Inc · Cytek Biosciences Inc

AZTA

Azenta Inc

CTKB

Cytek Biosciences Inc

Compare $AZTA vs $CTKB

Comparing Azenta Inc and Cytek Biosciences Inc

AZTAAzenta Inc

CTKBCytek Biosciences Inc

AZTAAzenta Inc

Market cap

$1.74B

P/E (TTM)

—

Forward P/E (NTM)

66.47x

Forward P/S (NTM)

2.69x

Rev growth (TTM)

1.4%

YTD performance

13.0%

52W performance

17.0%

FCF yield

0.6%

CTKBCytek Biosciences Inc

Market cap

$701M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.18x

Rev growth (TTM)

5.4%

YTD performance

10.4%

52W performance

39.2%

FCF yield

-1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AZTA

CTKB

Detailed metrics comparison

AZTA

Azenta Inc

CTKB

Cytek Biosciences Inc

Market Cap

AZTA$1.74B

CTKB$701M

Enterprise Value

AZTA$1.55B

CTKB$637M

Price

AZTA$37.72

CTKB$5.43

P/E Ratio

AZTAN/A

CTKBN/A

P/S Ratio

AZTA2.83x

CTKB3.39x

EV/Sales

AZTA2.52x

CTKB3.08x

EV/EBITDA

AZTA37.55x

CTKB1,027.69x

P/B Ratio

AZTA1.12x

CTKB2.37x

P/FCF Ratio

AZTA175.95x

CTKBN/A

EV/FCF

AZTA156.75x

CTKB-52.35x

PEG Ratio

AZTAN/A

CTKBN/A

Forward P/E (NTM)

AZTA66.47x

CTKBN/A

Forward P/S (NTM)

AZTA2.69x

CTKB3.18x

Revenue (TTM)

AZTA$614M

CTKB$207M

Revenue Growth (YoY)

AZTA1.4%

CTKB5.4%

Forward Rev Growth

AZTA5.4%

CTKB6.1%

Gross Margin (TTM)

AZTA43.4%

CTKB53.2%

Operating Margin (TTM)

AZTA0.0%

CTKB0.0%

EBITDA Margin (TTM)

AZTA5.3%

CTKB-17.9%

Net Margin (TTM)

AZTA-20.0%

CTKB-39.0%

FCF Margin (TTM)

AZTA1.6%

CTKB-5.9%

Net Income (TTM)

AZTA$-123M

CTKB$-81M

FCF (TTM)

AZTA$10M

CTKB$-12M

EPS (TTM)

AZTA-$2.71

CTKB-$0.62

ROE (TTM)

AZTA-756.0%

CTKB-2353.0%

ROA (TTM)

AZTA-621.0%

CTKB-1740.0%

ROIC (TTM)

AZTA-756.0%

CTKB-2293.0%

Cash

AZTA$190M

CTKB$74M

Debt

AZTA$0

CTKB$10M

Net Cash/Debt

AZTA$190M

CTKB$64M

Current Ratio (TTM)

AZTA2.50x

CTKB4.48x

Quick Ratio (TTM)

AZTA2.12x

CTKB3.77x

Debt/Equity (TTM)

AZTA0.00x

CTKB0.03x

Debt/Assets (TTM)

AZTA0.0%

CTKB0.0%

Interest Coverage (TTM)

AZTAN/A

CTKBN/A

Net Debt/EBITDA (TTM)

AZTA0.00x

CTKB0.00x

Beta

AZTA1.51

CTKB1.15

52W Performance

AZTA17.0%

CTKB39.2%

YTD Performance

AZTA13.0%

CTKB10.4%

% from 52W High

AZTA-18.7%

CTKB-12.6%

% from 52W Low

AZTA136.8%

CTKB64.0%

Asset Turnover (TTM)

AZTA0.31x

CTKB0.45x

FCF Yield (TTM)

AZTA0.6%

CTKB-1.7%

Earnings Yield (TTM)

AZTA-7.1%

CTKB-11.5%

Dividend Yield (TTM)

AZTAN/A

CTKBN/A

Rule of 40

AZTA3.0

CTKB-0.4

EV/GP/RG

AZTA0.83

CTKB0.61

Ticker research

View AZTA research View CTKB research

Metric	AZTA Azenta Inc	CTKB Cytek Biosciences Inc
Market & Valuation
Market Cap	$1.74B	$701M
Enterprise Value	$1.55B	$637M
Price	$37.72	$5.43
P/E Ratio	N/A	N/A
P/S Ratio	2.83x	3.39x
EV/Sales	2.52x	3.08x
EV/EBITDA	37.55x	1,027.69x
P/B Ratio	1.12x	2.37x
P/FCF Ratio	175.95x	N/A
EV/FCF	156.75x	-52.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	66.47x	N/A
Forward P/S (NTM)	2.69x	3.18x
Revenue & Growth
Revenue (TTM)	$614M	$207M
Revenue Growth (YoY)	1.4%	5.4%
Forward Rev Growth	5.4%	6.1%
Profitability
Gross Margin (TTM)	43.4%	53.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5.3%	-17.9%
Net Margin (TTM)	-20.0%	-39.0%
FCF Margin (TTM)	1.6%	-5.9%
Net Income (TTM)	$-123M	$-81M
FCF (TTM)	$10M	$-12M
EPS (TTM)	-$2.71	-$0.62
ROE (TTM)	-756.0%	-2353.0%
ROA (TTM)	-621.0%	-1740.0%
ROIC (TTM)	-756.0%	-2293.0%
Financial Health
Cash	$190M	$74M
Debt	$0	$10M
Net Cash/Debt	$190M	$64M
Current Ratio (TTM)	2.50x	4.48x
Quick Ratio (TTM)	2.12x	3.77x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	1.15
52W Performance	17.0%	39.2%
YTD Performance	13.0%	10.4%
% from 52W High	-18.7%	-12.6%
% from 52W Low	136.8%	64.0%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.45x
FCF Yield (TTM)	0.6%	-1.7%
Earnings Yield (TTM)	-7.1%	-11.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-0.4
EV/GP/RG	0.83	0.61
Ticker research	View AZTA research	View CTKB research

Valuation

P/S Ratio

AZTA

2.83x

CTKB

3.39x

EV/FCF

CTKB

-52.35x

AZTA

156.75x

Growth & revenue

Revenue Growth TTM

CTKB

5.4%

AZTA

1.4%

Forward Revenue Growth

CTKB

6.1%

AZTA

5.4%

Profitability & performance

Gross Margin

CTKB

53.2%

AZTA

43.4%

ROE

AZTA

-756.0%

CTKB

-2353.0%

FCF Yield %

AZTA

0.6%

CTKB

-1.7%

52-Week Performance

CTKB

39.2%

AZTA

17.0%

Detailed metrics comparison

AZTA

Azenta Inc

CTKB

Cytek Biosciences Inc

Market Cap

AZTA$1.74B

CTKB$701M

Enterprise Value

AZTA$1.55B

CTKB$637M

Price

AZTA$37.72

CTKB$5.43

P/E Ratio

AZTAN/A

CTKBN/A

P/S Ratio

AZTA2.83x

CTKB3.39x

EV/Sales

AZTA2.52x

CTKB3.08x

EV/EBITDA

AZTA37.55x

CTKB1,027.69x

P/B Ratio

AZTA1.12x

CTKB2.37x

P/FCF Ratio

AZTA175.95x

CTKBN/A

EV/FCF

AZTA156.75x

CTKB-52.35x

PEG Ratio

AZTAN/A

CTKBN/A

Forward P/E (NTM)

AZTA66.47x

CTKBN/A

Forward P/S (NTM)

AZTA2.69x

CTKB3.18x

Revenue (TTM)

AZTA$614M

CTKB$207M

Revenue Growth (YoY)

AZTA1.4%

CTKB5.4%

Forward Rev Growth

AZTA5.4%

CTKB6.1%

Gross Margin (TTM)

AZTA43.4%

CTKB53.2%

Operating Margin (TTM)

AZTA0.0%

CTKB0.0%

EBITDA Margin (TTM)

AZTA5.3%

CTKB-17.9%

Net Margin (TTM)

AZTA-20.0%

CTKB-39.0%

FCF Margin (TTM)

AZTA1.6%

CTKB-5.9%

Net Income (TTM)

AZTA$-123M

CTKB$-81M

FCF (TTM)

AZTA$10M

CTKB$-12M

EPS (TTM)

AZTA-$2.71

CTKB-$0.62

ROE (TTM)

AZTA-756.0%

CTKB-2353.0%

ROA (TTM)

AZTA-621.0%

CTKB-1740.0%

ROIC (TTM)

AZTA-756.0%

CTKB-2293.0%

Cash

AZTA$190M

CTKB$74M

Debt

AZTA$0

CTKB$10M

Net Cash/Debt

AZTA$190M

CTKB$64M

Current Ratio (TTM)

AZTA2.50x

CTKB4.48x

Quick Ratio (TTM)

AZTA2.12x

CTKB3.77x

Debt/Equity (TTM)

AZTA0.00x

CTKB0.03x

Debt/Assets (TTM)

AZTA0.0%

CTKB0.0%

Interest Coverage (TTM)

AZTAN/A

CTKBN/A

Net Debt/EBITDA (TTM)

AZTA0.00x

CTKB0.00x

Beta

AZTA1.51

CTKB1.15

52W Performance

AZTA17.0%

CTKB39.2%

YTD Performance

AZTA13.0%

CTKB10.4%

% from 52W High

AZTA-18.7%

CTKB-12.6%

% from 52W Low

AZTA136.8%

CTKB64.0%

Asset Turnover (TTM)

AZTA0.31x

CTKB0.45x

FCF Yield (TTM)

AZTA0.6%

CTKB-1.7%

Earnings Yield (TTM)

AZTA-7.1%

CTKB-11.5%

Dividend Yield (TTM)

AZTAN/A

CTKBN/A

Rule of 40

AZTA3.0

CTKB-0.4

EV/GP/RG

AZTA0.83

CTKB0.61

Ticker research

View AZTA research View CTKB research

Metric	AZTA Azenta Inc	CTKB Cytek Biosciences Inc
Market & Valuation
Market Cap	$1.74B	$701M
Enterprise Value	$1.55B	$637M
Price	$37.72	$5.43
P/E Ratio	N/A	N/A
P/S Ratio	2.83x	3.39x
EV/Sales	2.52x	3.08x
EV/EBITDA	37.55x	1,027.69x
P/B Ratio	1.12x	2.37x
P/FCF Ratio	175.95x	N/A
EV/FCF	156.75x	-52.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	66.47x	N/A
Forward P/S (NTM)	2.69x	3.18x
Revenue & Growth
Revenue (TTM)	$614M	$207M
Revenue Growth (YoY)	1.4%	5.4%
Forward Rev Growth	5.4%	6.1%
Profitability
Gross Margin (TTM)	43.4%	53.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	5.3%	-17.9%
Net Margin (TTM)	-20.0%	-39.0%
FCF Margin (TTM)	1.6%	-5.9%
Net Income (TTM)	$-123M	$-81M
FCF (TTM)	$10M	$-12M
EPS (TTM)	-$2.71	-$0.62
ROE (TTM)	-756.0%	-2353.0%
ROA (TTM)	-621.0%	-1740.0%
ROIC (TTM)	-756.0%	-2293.0%
Financial Health
Cash	$190M	$74M
Debt	$0	$10M
Net Cash/Debt	$190M	$64M
Current Ratio (TTM)	2.50x	4.48x
Quick Ratio (TTM)	2.12x	3.77x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	1.15
52W Performance	17.0%	39.2%
YTD Performance	13.0%	10.4%
% from 52W High	-18.7%	-12.6%
% from 52W Low	136.8%	64.0%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.45x
FCF Yield (TTM)	0.6%	-1.7%
Earnings Yield (TTM)	-7.1%	-11.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3.0	-0.4
EV/GP/RG	0.83	0.61
Ticker research	View AZTA research	View CTKB research